NKTR – Nektar Therapeutics
Nektar TherapeuticsNKTR
$40.45Name : Nektar Therapeutics
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $822,817,280.00
EPSttm : -9.83
Nektar Therapeutics
$40.45
2.39%$0.99Float Short %
9.62
Margin Of Safety %
Put/Call OI Ratio
0.44
EPS Next Q Diff
-0.72
EPS Last/This Y
0.38
EPS This/Next Y
-3.54
Price
41.41
Target Price
114.43
Analyst Recom
1.22
Performance Q
-26.73
Relative Volume
0.68
Beta
-0.97
Ticker: NKTR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-10 | NKTR | 57.62 | 0.27 | 0.11 | 30524 |
| 2025-12-11 | NKTR | 51.07 | 0.27 | 0.56 | 30872 |
| 2025-12-12 | NKTR | 54.83 | 0.29 | 0.47 | 31232 |
| 2025-12-15 | NKTR | 53.3 | 0.29 | 0.30 | 31838 |
| 2025-12-16 | NKTR | 49.08 | 0.28 | 0.40 | 32501 |
| 2025-12-17 | NKTR | 45.46 | 0.31 | 0.89 | 33266 |
| 2025-12-18 | NKTR | 44.08 | 0.36 | 0.80 | 36512 |
| 2025-12-19 | NKTR | 46.81 | 0.33 | 0.54 | 36003 |
| 2025-12-22 | NKTR | 43.41 | 0.39 | 0.19 | 23200 |
| 2025-12-23 | NKTR | 44.53 | 0.42 | 1.00 | 22949 |
| 2025-12-26 | NKTR | 44.54 | 0.45 | 0.92 | 23572 |
| 2025-12-29 | NKTR | 42.65 | 0.45 | 0.96 | 23774 |
| 2025-12-30 | NKTR | 41.84 | 0.44 | 0.98 | 23815 |
| 2025-12-31 | NKTR | 42.19 | 0.44 | 0.78 | 23931 |
| 2026-01-02 | NKTR | 43.41 | 0.45 | 0.18 | 23986 |
| 2026-01-05 | NKTR | 44.38 | 0.44 | 0.20 | 24047 |
| 2026-01-06 | NKTR | 42.94 | 0.44 | 0.22 | 24129 |
| 2026-01-07 | NKTR | 43.47 | 0.44 | 0.08 | 24234 |
| 2026-01-08 | NKTR | 41.38 | 0.44 | 0.05 | 24327 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-10 | NKTR | 57.69 | -46.2 | - | -11.59 |
| 2025-12-11 | NKTR | 51.10 | -46.2 | - | -11.59 |
| 2025-12-12 | NKTR | 54.70 | -46.2 | - | -11.59 |
| 2025-12-15 | NKTR | 53.30 | -46.2 | - | -11.59 |
| 2025-12-16 | NKTR | 53.30 | -46.2 | - | -11.59 |
| 2025-12-17 | NKTR | 45.43 | -46.2 | - | -11.59 |
| 2025-12-18 | NKTR | 44.06 | -46.2 | - | -7.97 |
| 2025-12-19 | NKTR | 46.85 | -28.9 | - | -7.97 |
| 2025-12-22 | NKTR | 43.35 | -28.9 | - | -8.32 |
| 2025-12-23 | NKTR | 44.29 | -28.9 | - | -8.32 |
| 2025-12-26 | NKTR | 44.50 | -28.9 | - | -8.32 |
| 2025-12-29 | NKTR | 42.70 | -28.9 | - | -8.32 |
| 2025-12-30 | NKTR | 41.84 | -28.9 | - | -8.32 |
| 2025-12-31 | NKTR | 42.26 | -28.9 | - | -8.32 |
| 2026-01-02 | NKTR | 43.38 | -28.9 | - | -8.32 |
| 2026-01-05 | NKTR | 44.38 | -28.9 | - | -8.32 |
| 2026-01-06 | NKTR | 42.96 | -28.9 | - | -8.32 |
| 2026-01-07 | NKTR | 43.49 | -28.9 | - | -8.32 |
| 2026-01-08 | NKTR | 41.41 | -28.9 | - | -8.32 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-10 | NKTR | -9.06 | 41.14 | 9.07 |
| 2025-12-11 | NKTR | -9.06 | 41.14 | 9.07 |
| 2025-12-12 | NKTR | -9.06 | 41.14 | 9.07 |
| 2025-12-15 | NKTR | -9.06 | 41.12 | 9.06 |
| 2025-12-16 | NKTR | -9.60 | 41.12 | 9.06 |
| 2025-12-17 | NKTR | -9.60 | 41.12 | 9.06 |
| 2025-12-18 | NKTR | -9.60 | 41.12 | 9.06 |
| 2025-12-19 | NKTR | -9.60 | 41.12 | 9.06 |
| 2025-12-22 | NKTR | -9.60 | 40.25 | 9.06 |
| 2025-12-23 | NKTR | -9.60 | 40.25 | 9.06 |
| 2025-12-26 | NKTR | -9.60 | 40.25 | 9.60 |
| 2025-12-29 | NKTR | -9.60 | 40.38 | 9.62 |
| 2025-12-30 | NKTR | -8.83 | 40.38 | 9.62 |
| 2025-12-31 | NKTR | -8.83 | 40.38 | 9.62 |
| 2026-01-02 | NKTR | -8.83 | 40.38 | 9.62 |
| 2026-01-05 | NKTR | -8.83 | 40.27 | 9.62 |
| 2026-01-06 | NKTR | -8.83 | 40.27 | 9.62 |
| 2026-01-07 | NKTR | -8.83 | 40.27 | 9.62 |
| 2026-01-08 | NKTR | -8.83 | 40.27 | 9.62 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.87
Avg. EPS Est. Current Quarter
-2.9
Avg. EPS Est. Next Quarter
-2.59
Insider Transactions
-8.83
Institutional Transactions
40.27
Beta
-0.97
Average Sales Estimate Current Quarter
10
Average Sales Estimate Next Quarter
10
Fair Value
Quality Score
35
Growth Score
23
Sentiment Score
89
Actual DrawDown %
89.7
Max Drawdown 5-Year %
-98.3
Target Price
114.43
P/E
Forward P/E
PEG
P/S
13.47
P/B
9.57
P/Free Cash Flow
EPS
-7.94
Average EPS Est. Cur. Y
-8.32
EPS Next Y. (Est.)
-11.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-192.87
Relative Volume
0.68
Return on Equity vs Sector %
-169.2
Return on Equity vs Industry %
-153.8
EPS 1 7Days Diff
-8.3
EPS 1 30Days Diff
-8.32
EBIT Estimation
Nektar TherapeuticsSector: Healthcare
Industry: Biotechnology
Employees: 61
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
stock quote shares NKTR – Nektar Therapeutics Stock Price stock today
news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025
marketwatch NKTR – Nektar Therapeutics yahoo finance google finance
stock history NKTR – Nektar Therapeutics invest stock market
stock prices NKTR premarket after hours
ticker NKTR fair value insiders trading